Wealth Enhancement Advisory Services, LLC Gilead Sciences, Inc. Transaction History

Wealth Enhancement Advisory Services, LLC

$55.6 Billion
Q2 2025

A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 484,018 shares of GILD stock, worth $60.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

484,018

Previous 292,966 65.21%

Holding current value

$60.1 Million

Previous $32.8 Million 63.48%

% of portfolio

0.1%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 10, 2025	BUY	$96.91 - $113.0 $18.5 Million - $21.6 Million	191,052 Added 65.21%	484,018 $53.7 Million
Q1 2025 Apr 16, 2025	BUY	$89.14 - $117.41 $1.18 Million - $1.55 Million	13,194 Added 4.72%	292,966 $32.8 Million
Q4 2024 Mar 17, 2025	SELL	$83.95 - $97.9 $3.75 Million - $4.38 Million	-44,697 Reduced 13.78%	279,772 $25.8 Million
Q4 2024 Jan 10, 2025	BUY	$83.95 - $97.9 $122,399 - $142,738	1,458 Added 0.45%	324,469 $30 Million
Q3 2024 Oct 23, 2024	BUY	$66.59 - $83.99 $2.46 Million - $3.1 Million	36,895 Added 12.9%	323,011 $27.1 Million
Q2 2024 Jul 16, 2024	BUY	$63.15 - $72.88 $2.09 Million - $2.42 Million	33,162 Added 13.11%	286,116 $19.6 Million
Q1 2024 Apr 15, 2024	SELL	$71.58 - $87.29 $764,116 - $931,820	-10,675 Reduced 4.05%	252,954 $18.5 Million
Q4 2023 Jan 30, 2024	BUY	$73.27 - $83.09 $3.55 Million - $4.03 Million	48,509 Added 22.55%	263,629 $21.4 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $11.7 Million - $12.8 Million	158,912 Added 282.72%	215,120 $16.1 Million
Q2 2023 Jul 21, 2023	BUY	$76.01 - $86.7 $22,042 - $25,143	290 Added 0.52%	56,208 $4.33 Million
Q1 2023 Apr 25, 2023	BUY	$77.31 - $88.08 $4.32 Million - $4.93 Million	55,918 New	55,918 $4.64 Million
Q2 2022 Jul 18, 2022	SELL	$57.72 - $65.01 $5.92 Million - $6.67 Million	-102,618 Closed	0 $0
Q1 2022 Apr 18, 2022	BUY	$57.92 - $72.58 $356,208 - $446,367	6,150 Added 6.38%	102,618 $6.23 Million
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $2.78 Million - $3.16 Million	-42,870 Reduced 30.77%	96,468 $6.58 Million
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $8.87 Million - $10.3 Million	122,554 Added 730.18%	139,338 $12.9 Million
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $1.05 Million - $1.35 Million	16,784 New	16,784 $1.32 Million
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $3.32 Million - $3.66 Million	-53,052 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$61.87 - $69.38 $3.28 Million - $3.68 Million	53,052 New	53,052 $3.6 Million
Q1 2018 Apr 26, 2018	SELL	$72.84 - $88.8 $898,481 - $1.1 Million	-12,335 Closed	0 $0
Q4 2017 Jan 19, 2018	BUY	$71.15 - $83.52 $13,376 - $15,701	188 Added 1.55%	12,335 $975,000
Q3 2017 Oct 18, 2017	BUY	$72.11 - $85.47 $875,920 - $1.04 Million	12,147	12,147 $998,000

Others Institutions Holding GILD

# of Institutions

2,338

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.

Account

Wealth Enhancement Advisory Services, LLC Gilead Sciences, Inc. Transaction History